Repurposing Licensed Drugs with Activity Against Epstein–Barr Virus for Treatment of Multiple Sclerosis: A Systematic Approach

Vivien Li, Fiona C. McKay, David C. Tscharke et al.|CNS Drugs|2025

Cited by 14